Heuron Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Heuron Co., Ltd. - overview
Established
2017
Location
Seoul, -, South Korea
Primary Industry
Healthcare IT
About
Based in Seoul, South Korea, and established in 2017, Heuron Co. , Ltd. operates as a medical AI development company that provides treatment solutions for central nervous system disorders. The company's president and chief executive officer Donghoon Shin graduated from Ajou University College of Medicine.
He is an associate professor at Gachon University Gil Medical Center. In February 2021, it obtained NET(New Excellent Technology) certification for Nigrosome biomarker discovery technology in MR imaging. In July 2020, it obtained MFDS (Class II) certification for Medical Image Analysis Device Software. The company has partnerships with Ajou University Hospital, Gangnam Severance Hospital, and Seoul St.
Mary's Hospital. The company has more than 20 clinical data-centered diagnostic programs under development for Parkinson's disease, dementia, stroke, and brain tumors?. The company has developed AI software enabling early diagnosis of degenerative diseases of the brain.
Current Investors
AJU IB Investment, Smilegate Investment, JB Investment
Primary Industry
Healthcare IT
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Medical Software
Website
www.iheuron.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Heuron Co., Ltd. - timeline of key events
Heuron Co., Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.